Diffuse-regressive alterations and apoptosis of myocytes: Possible causes of myocardial dysfunction in HIV-related cardiomyopathy

International Journal of Cardiology

Volumn 132, Issue 1, 2009, Pages 90-95

  Pozzan, Geanete ^a   Pagliari, Carla ^b   Tuon, Felipe Francisco ^c   Takakura, Cleusa Fumika ^b   Kauffman, Monica R ^b   Duarte, Maria Irma Seixas ^b  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b Faculty of Medical Sciences   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Apoptosis; Dilated cardiomyopathy; Heart; HIV infection; Myocarditis

Indexed keywords

LIPOFUSCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AIDS PATIENT; APOPTOSIS; ARTICLE; AUTOPSY; CAPILLARY ENDOTHELIUM; CARDIOMYOPATHY; CELL LOSS; CELL ULTRASTRUCTURE; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; HEART DILATATION; HEART MUSCLE CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MITOCHONDRIAL VOLUME; MORBIDITY; MUSCLE FIBRIL; MYOCARDITIS; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 58849109562     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.057     Document Type: Article

References (38)

1. Barbaro G., Di L.G., Grisorio B., and Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retrovir 14 (1998) 1071-1077
2. Anderson D.W., Virmani R., Reilly J.M., et al. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 11 (1998) 792-799
3. Barbaro G., Di L.G., Grisorio B., and Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339 (1998) 1093-1099
4. Fink L., Reichek N., and Sutton M.G. Cardiac abnormalities in acquired immune deficiency syndrome. Am J Cardiol 54 (1984) 1161-1163
5. Okoshi M.P., and Montenegro M.R. Patologia do coração na AIDS. Estudo de 73 necrópsias consecutivas. Arq Bras Cardiol 66 (1996) 133
6. Cammarosano C., and Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am Coll Cardiol 5 (1985) 703-706
7. Lewis W., Lipsick J., and Cammarosano C. Cryptococcal myocarditis in acquired immune deficiency syndrome. Am J Cardiol 55 (1985) 1240
8. Hansen B.F. Pathology of the heart in AIDS. A study of 60 consecutive autopsies. APMIS 100 (1992) 273-279
9. Lanjewar D.N., Katdare G.A., Jain P.P., and Hira S.K. Pathology of the heart in acquired immunodeficiency syndrome. Indian Heart J 50 (1998) 321-325
10. Roldan E.O., Moskowitz L., and Hensley G.T. Pathology of the heart in acquired immunodeficiency syndrome. Arch Pathol Lab Med 111 (1987) 943-946
11. Lipshultz S.E., Easley K.A., Orav E.J., et al. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation 97 (1998) 1246-1256
12. Herskowitz A., Willoughby S.B., Vlahov D., Baughman K.L., and Ansari A.A. Dilated heart muscle disease associated with HIV infection. Eur Heart J 16 (1995) 50-55 Suppl O
13. Currie P.F., Jacob A.J., Foreman A.R., Elton R.A., Brettle R.P., and Boon N.A. Heart muscle disease related to HIV infection: prognostic implications. BMJ 309 (1994) 1605-1607
14. Barbaro G., Di L.G., Soldini M., et al. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 100 (1999) 933-939
15. Aretz H.T. Myocarditis: the Dallas criteria. Hum Pathol 18 (1987) 619-624
16. Duarte M.I., Mariano O.N., Takakura C.F., Everson D., and Corbett C.E. A fast method for processing biologic material for electron microscopic diagnosis in infectious disease. Ultrastruct Pathol 16 (1992) 475-482
17. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation 106 (2002) 1420-1425
18. Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS 17 Suppl 1 (2003) S12-S20
19. Rerkpattanapipat P., Wongpraparut N., Jacobs L.E., and Kotler M.N. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 160 (2000) 602-608
20. McKenna C.J., Sugrue D.D., Kwon H.M., et al. Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathy. Am J Cardiol 83 (1999) 281-283 A6
21. Saraste A., and Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45 (2000) 528-537
22. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 45 (2000) 630-641
23. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335 (1996) 1182-1189
24. Sabbah H.N. Apoptotic cell death in heart failure. Cardiovasc Res 45 (2000) 704-712
25. Kockx M.M., and Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc Res 45 (2000) 736-746
26. Twu C., Liu N.Q., Popik W., et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion-and death receptor-controlled pathways. Proc Natl Acad Sci U S A 99 (2002) 14386-14391
27. Monsuez J.J., Escaut L., Teicher E., Charniot J.C., and Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol 120 (2007) 150-157
28. Lewis W., Miller Y.K., Haase C.P., et al. HIV viral protein R causes atrial cardiomyocyte mitosis, mesenchymal tumor, dysrhythmia, and heart failure. Lab Invest 85 (2005) 182-192
29. Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr Opin Cardiol 11 (1996) 325-331
30. Herskowitz A., Willoughby S., Wu T.C., et al. Immunopathogenesis of HIV-1-associated cardiomyopathy. Clin Immunol Immunopathol 68 (1993) 234-241
31. Pulkki K.J. Cytokines and cardiomyocyte death. Ann Med 29 (1997) 339-343
32. Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 11 (1996) 302-309
33. Fisher S.D., Bowles N.E., Towbin J.A., and Lipshultz S.E. Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes. AIDS 17 Suppl 1 (2003) S29-S35
34. Haywood G.A., Tsao P.S., von der Leyen H.E., et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93 (1996) 1087-1094
35. Lewis W., Haase C.P., Miller Y.K., et al. Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Lab Invest 85 (2005) 972-981
36. Lewis W., Haase C.P., Raidel S.M., et al. Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice. Lab Invest 81 (2001) 1527-1536
37. Lamperth L., Dalakas M.C., Dagani F., Anderson J., and Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest 65 (1991) 742-751
38. Sutliff R.L., Haase C., Russ R., et al. Cocaine increases mortality and cardiac mass in a murine transgenic model of acquired immune deficiency syndrome. Lab Invest 83 (2003) 983-989